Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04444349Recruiting
Randomised, open-label trial (2 arms), sponsored by Nanjing Medical University. Primary endpoint: C-reactive protein. Started Feb 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04444349.